• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二甲双胍可减轻轻度高血糖 Oikawa-Nagao 小鼠的早期动脉粥样硬化。

Metformin Attenuates Early-Stage Atherosclerosis in Mildly Hyperglycemic Oikawa-Nagao Mice.

机构信息

Department of Endocrinology, Diabetes and Metabolism, Graduate School of Medicine, Nippon Medical School.

Food and Health Science Research Unit, Graduate School of Agricultural Science, Tohoku University.

出版信息

J Atheroscler Thromb. 2019 Dec 1;26(12):1075-1083. doi: 10.5551/jat.48223. Epub 2019 Apr 11.

DOI:10.5551/jat.48223
PMID:30971640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6927811/
Abstract

AIM

Although metformin treatment has been reported to reduce the risk of cardiovascular events in patients with type 2 diabetes, the underlying mechanisms have not been elucidated fully. Here we assessed atherosclerotic lesion formation in newly established 2 mouse lines with different blood glucose levels (Oikawa-Nagao Diabetes-Prone [ON-DP] and -Resistant [ON-DR]) to evaluate the effect of metformin on early-stage atherosclerosis.

METHODS

Mildly hyperglycemic ON-DP and normoglycemic ON-DR female mice fed an atherogenic diet for 20 weeks (8-28 weeks of age). During the feeding period, one group of each mouse line received metformin in drinking water (0.1%), while another group received water alone as control. Atherosclerotic lesion formation in the aortic sinus was quantitively analyzed from the oil red O-stained area of the serial sections.

RESULTS

Metformin treatment did not affect food intake, body weight, and casual blood glucose levels within each mouse line during the 20-week feeding period. Nevertheless, metformin treatment significantly reduced atherosclerotic lesion formation in the ON-DP mice (59% of control), whereas no significant effect of metformin was observed in the lesion size of the ON-DR mice.

CONCLUSION

Metformin can attenuate early-stage atherogenesis in mildly hyperglycemic ON-DP mice. Pleiotropic effects of metformin, beyond its glucose-lowering action, may contribute to the antiatherogenic property in the early-stage atherosclerosis.

摘要

目的

尽管已有报道称二甲双胍治疗可降低 2 型糖尿病患者发生心血管事件的风险,但其中的具体机制尚未完全阐明。本研究通过评估两种不同血糖水平(Oikawa-Nagao 糖尿病易感型[ON-DP]和耐异型[ON-DR])新建立的小鼠模型中动脉粥样硬化病变的形成,来评估二甲双胍对早期动脉粥样硬化的影响。

方法

对喂食致动脉粥样硬化饮食(8-28 周龄)的轻度高血糖 ON-DP 和正常血糖 ON-DR 雌性小鼠进行研究。在喂食期间,每组小鼠分别给予二甲双胍饮水(0.1%)或单独给予水作为对照。采用油红 O 染色连续切片的方法定量分析主动脉窦处动脉粥样硬化病变的形成。

结果

在 20 周的喂食期间,二甲双胍处理并未影响各小鼠模型的饮食摄入、体重和随机血糖水平。然而,二甲双胍处理可显著减少 ON-DP 小鼠的动脉粥样硬化病变形成(对照组的 59%),而对 ON-DR 小鼠的病变大小无明显影响。

结论

二甲双胍可减轻轻度高血糖 ON-DP 小鼠的早期动脉粥样硬化形成。除了降低血糖作用之外,二甲双胍的多效性作用可能有助于其发挥早期抗动脉粥样硬化特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcce/6927811/0fe53b0e884b/jat-26-1075-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcce/6927811/9cc6fc7f2dff/jat-26-1075-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcce/6927811/db70e2e0f98f/jat-26-1075-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcce/6927811/de4357c48de3/jat-26-1075-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcce/6927811/3001e90a49cd/jat-26-1075-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcce/6927811/0fe53b0e884b/jat-26-1075-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcce/6927811/9cc6fc7f2dff/jat-26-1075-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcce/6927811/db70e2e0f98f/jat-26-1075-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcce/6927811/de4357c48de3/jat-26-1075-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcce/6927811/3001e90a49cd/jat-26-1075-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcce/6927811/0fe53b0e884b/jat-26-1075-g005.jpg

相似文献

1
Metformin Attenuates Early-Stage Atherosclerosis in Mildly Hyperglycemic Oikawa-Nagao Mice.二甲双胍可减轻轻度高血糖 Oikawa-Nagao 小鼠的早期动脉粥样硬化。
J Atheroscler Thromb. 2019 Dec 1;26(12):1075-1083. doi: 10.5551/jat.48223. Epub 2019 Apr 11.
2
Effect of impaired glucose tolerance on atherosclerotic lesion formation: an evaluation in selectively bred mice with different susceptibilities to glucose intolerance.糖耐量受损对动脉粥样硬化病变形成的影响:在对葡萄糖耐量不同敏感的选择性繁殖小鼠中的评估。
Atherosclerosis. 2013 Dec;231(2):421-6. doi: 10.1016/j.atherosclerosis.2013.10.009. Epub 2013 Oct 17.
3
Leptin production capacity determines food intake and susceptibility to obesity-induced diabetes in Oikawa-Nagao Diabetes-Prone and Diabetes-Resistant mice.瘦素产生能力决定了及川-长尾糖尿病易感性和抗性小鼠的食物摄入量和肥胖诱导糖尿病的易感性。
Diabetologia. 2020 Sep;63(9):1836-1846. doi: 10.1007/s00125-020-05191-8. Epub 2020 Jun 19.
4
Repetitive Glucose Spikes Accelerate Atherosclerotic Lesion Formation in C57BL/6 Mice.重复性血糖峰值加速C57BL/6小鼠动脉粥样硬化病变形成
PLoS One. 2015 Aug 27;10(8):e0136840. doi: 10.1371/journal.pone.0136840. eCollection 2015.
5
Metformin beyond diabetes: pleiotropic benefits of metformin in attenuation of atherosclerosis.二甲双胍的糖尿病外作用:二甲双胍在减轻动脉粥样硬化方面的多效性益处。
J Am Heart Assoc. 2014 Dec;3(6):e001202. doi: 10.1161/JAHA.114.001202.
6
Metformin inhibited Nod-like receptor protein 3 inflammasomes activation and suppressed diabetes-accelerated atherosclerosis in apoE mice.二甲双胍抑制核苷酸结合寡聚化结构域样受体蛋白 3 炎性小体的激活,并抑制载脂蛋白 E 小鼠的糖尿病加速动脉粥样硬化。
Biomed Pharmacother. 2019 Nov;119:109410. doi: 10.1016/j.biopha.2019.109410. Epub 2019 Sep 10.
7
Metformin reduces body weight gain and improves glucose intolerance in high-fat diet-fed C57BL/6J mice.二甲双胍可降低高脂饮食喂养的 C57BL/6J 小鼠的体重增加并改善葡萄糖不耐受。
Biol Pharm Bull. 2010;33(6):963-70. doi: 10.1248/bpb.33.963.
8
Selectively bred rodent models for studying the etiology of type 2 diabetes: Goto-Kakizaki rats and Oikawa-Nagao mice.用于研究2型糖尿病病因的选择性繁殖啮齿动物模型:五岛 - 柿崎大鼠和及川 - 长尾小鼠。
Endocr J. 2023 Jan 30;70(1):19-30. doi: 10.1507/endocrj.EJ22-0253. Epub 2022 Dec 7.
9
C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis.以高脂饮食喂养的C57BL/6小鼠作为糖尿病加速动脉粥样硬化的模型。
Atherosclerosis. 1998 Jan;136(1):17-24. doi: 10.1016/s0021-9150(97)00165-2.
10
[D-LEU-4]-OB3, a synthetic leptin agonist, improves hyperglycemic control in C57BL/6J ob/ob mice.[D-亮氨酸-4]-OB3,一种合成的瘦素激动剂,可改善C57BL/6J ob/ob小鼠的血糖控制。
Regul Pept. 2001 Sep 15;101(1-3):123-9. doi: 10.1016/s0167-0115(01)00274-9.

引用本文的文献

1
Genkwanin glycosides are major active compounds in Phaleria nisidai extract mediating improved glucose homeostasis by stimulating glucose uptake into adipose tissues.芫花苷类化合物是海滨巴豆提取物中的主要活性成分,通过刺激脂肪组织对葡萄糖的摄取来调节改善葡萄糖稳态。
Nat Commun. 2025 Aug 16;16(1):7648. doi: 10.1038/s41467-025-62689-8.
2
Unraveling the pathophysiology of type 2 diabetes with a new selectively bred animal model, the Oikawa-Nagao mouse.利用一种新的选择性培育动物模型——及川-长尾小鼠,揭示2型糖尿病的病理生理学机制。
Diabetol Int. 2025 Jan 5;16(1):13-22. doi: 10.1007/s13340-024-00784-9. eCollection 2025 Jan.
3
Metformin Reduces the Progression of Atherogenesis by Regulating the Sestrin2-mTOR Pathway in Obese and Diabetic Rats.

本文引用的文献

1
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2018 年美国糖尿病协会(ADA)和欧洲糖尿病研究协会(EASD)的共识报告:2 型糖尿病患者高血糖的管理。
Diabetologia. 2018 Dec;61(12):2461-2498. doi: 10.1007/s00125-018-4729-5.
2
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.日本动脉粥样硬化协会(JAS)2017年动脉粥样硬化性心血管疾病预防指南。
J Atheroscler Thromb. 2018 Sep 1;25(9):846-984. doi: 10.5551/jat.GL2017. Epub 2018 Aug 22.
3
二甲双胍通过调节肥胖和糖尿病大鼠的Sestrin2-mTOR通路来减少动脉粥样硬化的进展。
J Lipid Atheroscler. 2023 Sep;12(3):290-306. doi: 10.12997/jla.2023.12.3.290. Epub 2023 Sep 6.
4
Contribution of animal models to diabetes research: Its history, significance, and translation to humans.动物模型对糖尿病研究的贡献:其历史、意义及其向人类的转化。
J Diabetes Investig. 2023 Sep;14(9):1015-1037. doi: 10.1111/jdi.14034. Epub 2023 Jul 3.
5
Antioxidant, antihyperglycemic, and antihyperlipidemic properties of S. Y. Hu leaves in experimental animals: modulation of thioredoxin and glutathione systems, renal water reabsorption, and gut microbiota.SY胡树叶在实验动物中的抗氧化、降血糖和降血脂特性:对硫氧还蛋白和谷胱甘肽系统、肾脏水重吸收及肠道微生物群的调节
Front Nutr. 2023 Apr 28;10:1168049. doi: 10.3389/fnut.2023.1168049. eCollection 2023.
6
Metformin inhibits high glucose-induced smooth muscle cell proliferation and migration.二甲双胍抑制高糖诱导的平滑肌细胞增殖和迁移。
Aging (Albany NY). 2020 Mar 24;12(6):5352-5361. doi: 10.18632/aging.102955.
Japanese Clinical Practice Guideline for Diabetes 2016.
《2016年日本糖尿病临床实践指南》
J Diabetes Investig. 2018 Mar 26;9(3):657-97. doi: 10.1111/jdi.12810.
4
Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus.糖尿病患者动脉粥样硬化和心血管疾病的发病机制。
J Atheroscler Thromb. 2018 Jan 1;25(1):27-39. doi: 10.5551/jat.RV17014. Epub 2017 Sep 29.
5
The mechanisms of action of metformin.二甲双胍的作用机制。
Diabetologia. 2017 Sep;60(9):1577-1585. doi: 10.1007/s00125-017-4342-z. Epub 2017 Aug 3.
6
Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes.二甲双胍对心血管疾病的影响:一项对 2 型糖尿病患者随机试验的荟萃分析。
Diabetologia. 2017 Sep;60(9):1620-1629. doi: 10.1007/s00125-017-4337-9. Epub 2017 Aug 2.
7
Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data.二甲双胍对心脏和心血管系统的影响:实验与临床数据综述
Nutr Metab Cardiovasc Dis. 2017 Aug;27(8):657-669. doi: 10.1016/j.numecd.2017.04.009. Epub 2017 May 10.
8
AMPK activation reduces the number of atheromata macrophages in ApoE deficient mice.AMPK激活可减少载脂蛋白E缺陷小鼠动脉粥样硬化斑块中的巨噬细胞数量。
Atherosclerosis. 2017 Mar;258:97-107. doi: 10.1016/j.atherosclerosis.2017.01.036. Epub 2017 Feb 1.
9
Metformin Suppresses Diabetes-Accelerated Atherosclerosis via the Inhibition of Drp1-Mediated Mitochondrial Fission.二甲双胍通过抑制动力相关蛋白1(Drp1)介导的线粒体分裂来抑制糖尿病加速的动脉粥样硬化。
Diabetes. 2017 Jan;66(1):193-205. doi: 10.2337/db16-0915. Epub 2016 Oct 13.
10
Repetitive Glucose Spikes Accelerate Atherosclerotic Lesion Formation in C57BL/6 Mice.重复性血糖峰值加速C57BL/6小鼠动脉粥样硬化病变形成
PLoS One. 2015 Aug 27;10(8):e0136840. doi: 10.1371/journal.pone.0136840. eCollection 2015.